(Q43503033)

24 November 2017

title

Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy (English)

1 reference

24 November 2017

1 reference

Nousiainen I

1

1 reference

24 November 2017

Kälviäinen R

series ordinal

2

1 reference

24 November 2017

Mäntyjärvi M

series ordinal

3

1 reference

24 November 2017

publication date

1 May 2000

1 reference

24 November 2017

1 reference

24 November 2017

volume

107

1 reference

24 November 2017

issue

5

1 reference

24 November 2017

page(s)

884-888

1 reference

Severe persistent visual field constriction associated with vigabatrin

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Outer retinal dysfunction in patients treated with vigabatrin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Distribution of GABA immunoreactivity in kainic acid-treated rabbit retina

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

1 reference

7 January 2021

Place of newer antiepileptic drugs in the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

The influence of established and new antiepileptic drugs on visual perception. 1. A placebo-controlled, double-blind, single-dose study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

The influence of established and new antiepileptic drugs on visual perception. II. A controlled study in patients with epilepsy under long-term antiepileptic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Mechanisms of action of currently prescribed and newly developed antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

The effect of anti-epileptic drugs on visual perception in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Color vision tests for early detection of antiepileptic drug toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Proposals for scoring and assessing the 100-Hue test.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

Acquired dyschromatopsia in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900077-4

7 January 2021

10.1016/S0161-6420(00)00077-4

Identifiers

DOI

1 reference

24 November 2017

1 reference